Overview about pharmacoeconomics analysis and burden-of-illness in schizophrenia;Estudos farmacoeconômicos e carga da doença em esquizofrenia

Revista de Psiquiatria Clinica

Volumn 34, Issue SUPPL. 2, 2007, Pages 208-212

  Daltio, Claudiane Salles ^a,b   Mari, Jair De Jesus ^a   Ferraz, Marcos Bosi ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Centro Paulista de Economia da Saúde CPES   (Brazil)

Author keywords

Burden of illness; Cost off illness; Economic evaluation; Schizophrenia

Indexed keywords

BRAZIL; CANADA; COMMUNITY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DATA BASE; GENERAL ASPECTS OF DISEASE; HEALTH CARE POLICY; HEALTH ECONOMICS; HUMAN; MEDLINE; REVIEW; SCHIZOPHRENIA; UNITED KINGDOM;

EID: 36949028338     PISSN: 01016083     EISSN: 1806938X     Source Type: Journal    
DOI: 10.1590/S0101-60832007000800012     Document Type: Review

References (16)

1. Almond, S.; Knapp, M.; Francois, C.; Toumi, M.; Brugha, T. - Relapse in schizophrenia: costs, clinical outcomes and quality of life. Br J Psychiatry 184: 346-351, 2004.
2. Carr, V.J.; Neil, A.L.; Halpin, S.A.; Holmes, S.; Lewin, T.J. - Costs of schizophrenia and other psychoses in urban Australia: findings from the Low Prevalence (Psychotic) Disorders Study. Aust NZJ Psychiatry 37(1): 31-40, 2003.
3. Genduso, L.A.; Haley, J.C. - Cost of illness studies for schizophrenia: components, benefits, results, and implications. Am J Manag Care 3(6): 873-877, 1997.
4. Goeree, R.; Farahati, F.; Burke, N.; Blackhouse, G.; O'Reilly, D.; Pyne, J. - The economic burden of schizophrenia in Canada in 2004. Curr Med Res Opin 21(12): 2017-2028, 2005.
5. Grover, S.; Avasthi, A.; Chakrabarti, S.; Bhansali, A.; Kulhara, P. - Cost of care of schizophrenia: a study of Indian out-patient attenders. Acta Psychiatr Scand 112(1): 54-63, 2005.
6. Hu TW. - Perspectives: an international review of the national cost estimates of mental illness, 1990-2003. J Ment Health Policy Econ 9(1): 3-13, 2006.
7. Knapp, M.; King, D.; Pugner, K.; Lapuerta, P. Non-adherence to antipsychotic medication regimens: associations with resource use and costs. Br J Psychiatry 184: 509-516, 2004.
8. Knapp, M.; Mangalore, R.; Simon, J. - The global costs of schizophrenia. Schizophr Bull 30(2): 279-293, 2004.
9. Lang, H.C.; Su, T.P. - The cost of schizophrenia treatment in Taiwan. Psychiatr Serv 55(8): 928-930, 2004.
10. Leitão, R.J.; Ferraz, M.B.; Chaves, A.C.; Mari, J.J. - Cost of schizophrenia: direct costs and use of resources in the State of São Paulo. Rev Saude Publica 40(2): 304-309, 2006; epub, Mar 29th 2006.
11. Mangalore, R.; Knapp, M. - Cost of schizophrenia in England. J Ment Health Policy Econ 10(1): 23-41, 2007.
12. Tarricone, R.; Gerzeli, S.; Montanelli, R.; Frattura, L.; Percudani. M.; Racagni, G. - Direct and indirect costs of schizophrenia in community psychiatric services in Italy. The GISIES study. Interdisciplinary Study Group on the Economic Impact of Schizophrenia. Health Policy 51(1): 1-18, 2000.
13. Vázquez-Polo, F.J.; Negrín, M.; Cabasés, J.M.; Sánchez, E.; Haro, J.M.; Salvador-Carulla, L. - An analysis of the costs of treating schizophrenia in Spain: a hierarchical Bayesian approach. J Ment Health Policy Econ 8(3): 153-165, 2005.
14. World Health Organization - WHO. Mental health: new understanding, new hope. Geneva, 2001.
15. Wu, E.Q; Birnbaum, H.G.; Shi, L.; Ball, D.E.; Kessler, R.C.; Moulis, M. et al. - The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatry 66(9): 1122-1129, 2005.
16. Zanini, A.C; Wadt, M. - Farmacoeconomia - Tratado de Clínica Médica. 1.ed. São Paulo: Editora Roca,p. 370-378.